Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Change in Inventory (2021 - 2026)

Alvotech's (ALVO) quarterly Change in Inventory came in at -$403000.0 in Q2 2026, up 97.76% on a YoY basis from -$203785.3 in Q2 2025, and up 96.34% quarter-over-quarter from -$11.0 million in Q1 2026.

Analysis

Alvotech (ALVO) Change in Inventory (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Change in Inventory for 6 consecutive years, with -$403000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Inventory rose 97.76% year-over-year to -$403000.0; the trailing twelve-month figure through Jun 2026 stood at -$68.7 million (up 40.07% YoY), and the FY2025 full-year result was -$90.1 million, down 80.36% from the prior year.
  • Change in Inventory grew to -$403000.0 in Q2 2026 per ALVO's latest filing, from -$11.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at -$403000.0 in Q2 2026 and bottomed at -$53.0 million in Q3 2025.
  • Historically, Change in Inventory has averaged -$18.0 million across 5 years, with a median of -$11.9 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 546.1% in 2025, then soared 97.76% in 2026.
  • Over 5 years, Change in Inventory stood at -$32.4 million in 2022, then surged by 65.12% to -$11.3 million in 2023, then plunged by 342.08% to -$50.0 million in 2024, then soared by 91.48% to -$4.3 million in 2025, then jumped by 90.54% to -$403000.0 in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods registered -$403000.0, -$11.0 million, and -$4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -59.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 99.50 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -76.69 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 69.19 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 22.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -403,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -305,000.00
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 9.88 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -403,000.00
Mar 31, 2026 -11.02 Mn
Dec 31, 2025 -4.26 Mn
Sep 30, 2025 -53.03 Mn
Jun 30, 2025 -17.97 Mn
Mar 31, 2025 -14.87 Mn
Dec 31, 2024 -49.97 Mn
Sep 30, 2024 -31.85 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -12.42 Mn
Dec 31, 2023 -11.30 Mn
Jun 30, 2023 -4.13 Mn
Dec 31, 2022 -32.41 Mn
Jun 30, 2022 -4.91 Mn
Dec 31, 2021 -17.42 Mn
Sep 30, 2021 -1.72 Mn